Clinical Trials Logo
  1. Home
  2. Epithelioid Sarcoma
  3. NCT03099681

An Observational Study on Epithelioid Sarcoma — EPISObs  

Epithelioid Sarcoma Clinical Trial

Official title:
Epithelioid Sarcoma. An Observational Study

Clinical Trial Summary

Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)

Clinical Trial Description

The present prospective national study aims to provide a description of the population affected by ES, an insight into the natural history of the disease and an answer some on the outstanding questions on its management. Also, it will focus on enhancing any differences between the two ES variants (classical-type and proximal-type) in order gain a better understanding of the disease, tailor the treatment and lastly improve outcome. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03099681
Study type Observational
Source Italian Sarcoma Group
Contact Annamaria Frezza, MD
Phone 003902390
Email annamaria.frezza@istitutotumori.mi.it
Status Recruiting
Phase
Start date August 22, 2017
Completion date December 1, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04390737 - Evaluate the Safety and Clinical Activity of HH2853 Phase 1/Phase 2
Recruiting NCT05415098 - Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas Phase 1
Recruiting NCT05286801 - Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors Phase 1/Phase 2
Completed NCT00464620 - Trial of Dasatinib in Advanced Sarcomas Phase 2
Active, not recruiting NCT03069378 - A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma Phase 2
Completed NCT03837678 - Epithelioid Sarcoma Natural History Study
Active, not recruiting NCT02180867 - Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Phase 2/Phase 3
Recruiting NCT04008238 - Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients N/A
Completed NCT02584309 - Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Phase 2
Not yet recruiting NCT06277154 - MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma Phase 2
Completed NCT02601950 - A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma Phase 2
Completed NCT03190174 - Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Phase 1/Phase 2
Recruiting NCT04416568 - Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers Phase 2
Recruiting NCT05407441 - Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors Phase 1/Phase 2
Recruiting NCT03967834 - Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group N/A
No longer available NCT04225429 - Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma